Opinion
3:20-md-02966-RS
08-03-2023
IN RE XYREM (SODIUM OXYBATE) ANTITRUST LITIGATION
Jeffrey Faucette SKAGGS FAUCETTE LLP Heidi K. Hubbard (pro hac vice) Stanley E. Fisher (pro hac vice) Benjamin M. Greenblum (pro hac vice) WILLIAMS & CONNOLLY LLP Attorneys for Defendants Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited, and Jazz Pharmaceuticals Public Limited Company Dena C. Sharp Scott Grzenczyk Tom Watts Jordan Isern GIRARD SHARP LLP Michael M. Buchman (pro hac vice) Jacob Onile-Ere (pro hac vice) MOTLEY RICE LLC Co-Lead Class Counsel Jack E. Pace III (pro hac vice) WHITE & CASE LLP Kathryn J. Mims (pro hac vice) WHITE & CASE LLP WHITE & CASE LLP 3000 El Camino Real Attorneys for Defendants Hikma Pharmaceuticals PLC, Eurohealth (U.S.A.), Inc., West-Ward Pharmaceuticals Corp. n/k/a Hikma Pharmaceuticals USA Inc., and Roxane Laboratories, Inc. n/k/a Hikma Labs Inc. Devora W. Allon, P.C. (pro hac vice) Jay P. Lefkowitz, P.C. (pro hac vice) KIRKLAND & ELLIS LLP Attorneys for Defendants Lupin Pharmaceuticals Inc., Lupin Inc., and Lupin Ltd. Matthew H. Ladner (SBN 284594) TROUTMAN PEPPER HAMILTON SANDERS LLP Robin P. Sumner (pro hac vice) Melissa Hatch O'Donnell (pro hac vice) TROUTMAN PEPPER HAMILTON SANDERS LLP Attorneys for Defendant Amneal Pharmaceuticals LLC
Jeffrey Faucette SKAGGS FAUCETTE LLP
Heidi K. Hubbard (pro hac vice) Stanley E. Fisher (pro hac vice) Benjamin M. Greenblum (pro hac vice) WILLIAMS & CONNOLLY LLP
Attorneys for Defendants Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited, and Jazz Pharmaceuticals Public Limited Company
Dena C. Sharp Scott Grzenczyk Tom Watts Jordan Isern GIRARD SHARP LLP
Michael M. Buchman (pro hac vice) Jacob Onile-Ere (pro hac vice) MOTLEY RICE LLC
Co-Lead Class Counsel
Jack E. Pace III (pro hac vice) WHITE & CASE LLP
Kathryn J. Mims (pro hac vice) WHITE & CASE LLP
WHITE & CASE LLP 3000 El Camino Real
Attorneys for Defendants Hikma Pharmaceuticals PLC, Eurohealth (U.S.A.), Inc., West-Ward Pharmaceuticals Corp. n/k/a Hikma Pharmaceuticals USA Inc., and Roxane Laboratories, Inc. n/k/a Hikma Labs Inc.
Devora W. Allon, P.C. (pro hac vice) Jay P. Lefkowitz, P.C. (pro hac vice) KIRKLAND & ELLIS LLP
Attorneys for Defendants Lupin Pharmaceuticals Inc., Lupin Inc., and Lupin Ltd.
Matthew H. Ladner (SBN 284594) TROUTMAN PEPPER HAMILTON SANDERS LLP
Robin P. Sumner (pro hac vice) Melissa Hatch O'Donnell (pro hac vice) TROUTMAN PEPPER HAMILTON SANDERS LLP
Attorneys for Defendant Amneal Pharmaceuticals LLC
JOINT STIPULATION AND ORDER TO CHANGE THE DATE OF THE AUGUST 10, 2023 CASE MANAGEMENT CONFERENCE
HON. RICHARD SEEBORG, UNITED STATES CHIEF DISTRICT JUDGE
Pursuant to Civil Local Rules 6-2 and 7-12, Plaintiffs in the Consolidated Class Actions (“Class Plaintiffs”), Plaintiff United Healthcare Services, Inc. (“UHS”), Plaintiffs Humana Inc., Molina Healthcare, Inc., and Health Care Service Corporation, Inc. (with Class Plaintiffs, the “Plaintiffs”), and and Defendants Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited, and Jazz Pharmaceuticals Public Limited Company, Hikma Pharmaceuticals USA, Inc. (f/k/a WestWard Pharmaceuticals Corp.), Hikma Labs Inc. (f/k/a Roxane Laboratories, Inc.), Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals, Inc., and Lupin, Inc. (“Defendants”) (with Plaintiffs, the “Parties”) hereby stipulate and ask the Court to adjust the date of the next Case Management Conference in the above-referenced matter, currently set for Thursday, August 10, 2023, at 10:00 a.m., to August 17, 2023, at 10:00 a.m.:
WHEREAS, the Case Management Conference is currently set for August 10, 2023, at 10:00 a.m., but class counsel has a conflict at that time;
WHEREAS, the Parties have conferred and agree, subject to this Court's approval, to reschedule the Case Managemnt Conference to August 17, 2023;
WHEREAS, the Parties will submit their case management statement, as planned, on August 3, 2023;
WHEREAS, the proposed change of date will not alter the date of any event or any deadline already fixed by Court order;
NOW THEREFORE, the Parties, through their undersigned counsel, hereby stipulate and respectfully request that the Court enter an Order rescheduling the next Case Management Conference to August 17, 2023, at 10 a.m.
ATTESTATION PURSUANT TO CIVIL LOCAL RULE 5-1(i)(3)
I, Dena C. Sharp, am the ECF user whose identification and password are being used to file this document. In compliance with Local Rule 5-1(i)(3), I hereby attest that all signatories hereto concur in this filing.
ORDER
IT IS SO ORDERED.